Cinitapride Tartrate

酒石酸西尼必利

Report date: 2023/09/11 11:03:56
NME

Base Information

Drug NameCinitapride Tartrate
Drug Alias NameCinitapridum西尼必利酒石酸盐CinitapridaCinitaprideCidine +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsSerotonin 1a (5-HT1a) receptor agonistsSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 2 (5-HT2) receptorSerotonin 4 (5-HT4) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDyspepsiaGastroparesisGastroesophageal Reflux
Global Approved IndicationsDyspepsiaGastroparesisGastroesophageal Reflux
Approved Indications in ChinaDyspepsia
Original Approved Country/TerritorySpain
Original Approved Date1990/01/01
Country/TerritorySpainMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesIndustrias Farmaceuticas Almirall Sa
Inactive CompaniesEisai China Inc
Active IndicationsDyspepsiaGastroparesisGastroesophageal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeA03FA08
Related LinksWikipediaDrugBankKEGG